Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals

Journal of Medical Virology

Volumn 73, Issue 3, 2004, Pages 397-403

  Valcavi, Pierpaolo ^a,b   Medici, Maria Cristina ^a   Casula, Francesca ^a   Arcangeletti, Maria Cristina ^a   De Conto, Flora ^a   Pinardi, Federica ^a   Calderaro, Adriana ^a   Chezzi, Carlo ^a   Dettori, Giuseppe ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b Section of Microbiology   (Italy)

Author keywords

Core antigen detection; ELISA; Hepatitis C virus antigenaemia

Indexed keywords

HEPATITIS C ANTIGEN; HEPATITIS C CORE ANTIGEN; UNCLASSIFIED DRUG; VIRUS RNA;

ANTIBODY SPECIFICITY; ANTIGEN BLOOD LEVEL; ANTIGEN DETECTION; ARTICLE; BIOASSAY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS CORE ANTIGEN ASSAY; HUMAN; IMMUNOBLOTTING; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PERFORMANCE; POPULATION RESEARCH; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RECOMBINANT IMMUNOBLOT ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; VIREMIA;

ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HUMANS; IMMUNOBLOTTING; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VIRAL CORE PROTEINS; VIREMIA;

HEPATITIS C VIRUS;

EID: 2542491272     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20105     Document Type: Article

References (26)

1. Aoyagy K, Ohue C, Iida K, Kimura T, Tanaka E, Kiyosawa K, Yagi S. 1999. Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen. J Clin Microbiol 37:1802-1808.
2. Ballard AL, Boxall EH. 1999. Assessing the infectivity of hepatitis B carriers. Commun Dis Public Health 2:178-183.
3. Bellentani S, Miglioli L, Masutti F, Saccoccio G, Tiribelli C. 2000. Epidemiology of hepatitis C virus infection in Italy: The slowly unravelling mystery. Microbes Infect 2:1757-1763.
4. Blatt LM, Mutchnick MG, Tong MJ, Klion FM, Lebovics E, Freilich B, Bach N, Smith C, Herrera J, Tobias H, Conrad A, Schmid P, Mc Hutchinson JG. 2000. Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States. J Viral Hepatitis 7:196-202.
5. Bouvier-Alias M, Patel K, Dahari H, Beaucourt S, Larderie P, Blatt L, Hezode C, Picchio G, Dhumeaux D, Neuman A, Mc Hutchison J, Pawlotsky JM. 2002. Clinical utility of total HCV core antigen quantification: A new indirect marker of HCV replication. Hepatology 36:211-218.
6. Cano H, Candela MJ, Lozano ML, Vicente V. 2003. Application of a new enzyme-linked immunosorbent assay for detection of total hepatitis C virus core antigen in blood donors. Transfus Med 13:259-266.
7. Coppola RC, Rizzetto M, Bradley DW. 1996. Epatite C. In: Sorin Biomedica, editor. Manuale dell'epatite virale. pp 83-84.
8. Davis GL, Lau JY, Urdea MS, Neuwald PD, Wilbert JC, Lindsay K, Perrillo RP, Albrecht J. 1994. Quantitative detection of Hepatitis C virus RNA with a solid-phase signal amplification method: Definition of optimal conditions for specimen collection and clinical application in interferon-treated patients. Hepatology 19:1337-1341.
9. Halfon P, Khiri H, Gerolami V, Bourliere M, Fwryn JM, Reynier P, Gauthier A, Cartouzou G. 1996. Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA. J Hepatol 25:307-311.
10. Irving WL. 2002. The role of the virology laboratory in the management of hepatitis C virus infection. J Clin Virol 25:3-13.
11. Kanno A, Kazuyama Y. 2002. Immunoglobulin G antibody avidity assay for serodiagnosis of hepatitis C virus infection. J Med Virol 68:229-233.
12. Kurtz JB, Boxall E, Qusir N, Shirley J, Coleman D, Chandler C. 2001. The diagnostic significance of an assay for 'total' hepatitis C core antigen. J Virol Methods 96:127-132.
13. Laperche S, Le Marrec N, Simon N, Bouchardeau F, Defer C, Maniez-Montreuil M, Levayer T, Zappitelli JP, Lefrère JJ. 2003. A new HCV core antigen assay based on disassociation of immune-complexes: An alternative to molecular biology in the diagnosis of early HCV infection. Transfusion 43:958-962.
14. Lunel F, Veillon P, Fouchard-Hubert I, Loustaud-Ratti V, Abergel A, Silvain C, Rifflet H, Blanchi A, Causse X, Bacq Y, Payan C, Fontevraud Study Group. 2003. Antiviral effect of ribavirin in early non-responders to interferon monotherapy assessed by kinetics of hepatitis C virus RNA and hepatitis C virus core antigen. J Hepatol 39:826-833.
15. Maynard M, Pradat P, Berthillon P, Picchio G, Voirin N, Martinot M, Marcellin P, Trepo C. 2003. Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy. J Viral Hepatitis 10:318-323.
16. Mele A, Tosti ME, Marzolini A, Moiraghi A, Ragni P, Gallo G, Balocchino E, Santonastasi F, Stroffolini T. 2000. Prevention of hepatitis C in Italy: Lessons from surveillance of type-specific acute viral hepatitis. SEIEVA collaborating Group. J Viral Hepat 7:30-35.
17. Memon MI, Memon MA. 2002. Hepatitis C: An epidemiological review. J Viral Hepat 9:84-100.
18. Ramadori G, Meier V. 2001. Hepatitis C virus infection: 10 years after the discovery of the virus. Eur J Gastroenterol Hepatol 13:465-471.
19. Tanaka T, Lau JY, Mikokami M, Orito E, Tanaka R, Kiyosawa K, Yasui K, Ohta Y, Hasegawa A, Tanaka S, Kahawa H. 1995. Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viraemia. J Hepatol 26:742-745.
20. Tanaka Y, Takagi K, Fujihara T, Kitsugi K, Fujiwara K, Hiramatsu K, Ito Y, Takasaka y, Sakaj M, Mizokami M. 2003. High stability of enzyme immunoassay for hepatitis C virus core antigen-Evaluation before and after incubation at room temperature. Hepatol Res 26:261-267.
21. Trepo C, Pradat P. 1999. Hepatitis C virus infection in Western Europe. J Hepatol 1(31 Suppl):80-83.
22. Valcavi P, Natali A, Dieci E, Pilotti E, Chezzi C. 1999. Prevalence of hepatitis C virus antibodies in a clinic-based group of Italians from one geographic area. Clin Microbiol Infect 5:125-129.
23. Veillon P, Payan C, Picchio G, Maniez-Montreuil M, Guntz P, Lunel F. 2003. Comparative evaluation of the total hepatitis C virus core antigen, branched DNA, and amplicor monitor assay in determining viraemia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy. J Clin Microbiol 41:3212-3220.
24. Ward KN, Dhaliwal W, Ashworth KL, Clutterbuck EJ, Teo CG. 1994. Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody. J Med Virol 43:367-372.
25. WHO. 1997. Hepatitis C: Global prevalence. Wkly Epidemiol Rec 72:825-832.
26. Zanetti AR, Romanò L, Brunetto M, Colombo M, Bellati G, Tackney C. 2003. Total HCV core antigen assay: A new marker of hepatitis C viraemia for monitoring the progress of therapy. J Med Virol 70:27-30.